Investigators found that the first biosimilar of trastuzumab, trastuzumab-anns (Kanjinti; Amgen), did maintain a strong and persistent advantage over the other 4 biosimilar entrants.
USC Study Finds Biosimilars Drug Market Not Broken miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
On April 20, 2023, Senate Finance Committee Chair Senator Ron Wyden (D-OR) and Ranking Member Mike Crapo (R-ID) released a bipartisan framework for reducing prescription drug costs.
On April 20, 2023, Senate Finance Committee Chair Senator Ron Wyden (D-OR) and Ranking Member Mike Crapo (R-ID) released a bipartisan framework for reducing prescription drug costs and.
The USC-NCPA Pharmacy Access Initiative is aiming to help policymakers visualize the consequences of unfair PBM practices believed to contribute to pharmacy access issues by identifying shortage areas across the United States. So far, we’ve shown that nearly 1 in 4 neighborhoods nationwide are pharmacy shortage areas. Why is this happening and what can be done to ensure access to pharmacy care? This will be the focus of a webinar today featuring Rep.